← Insider buys
DRNA

Dicerna Pharmaceuticals Inc

Bain Capital Life Sciences Investors, LLC sold $20.0M of Dicerna Pharmaceuticals Inc

Director and 10% owner

Sold$20,000,000
$12.50Price
1,600,000Shares
−18%Stake

What DRNA did after the filing

Prices for DRNA after this filing aren't in yet.

Traded Wed, May 29. Filed Fri, May 31, 4:15 PM ET, after the close. Not investment advice.